% | $
Quotes you view appear here for quick access.

ForeverGreen Worldwide Corporation Message Board

  • gosnapgo gosnapgo Nov 19, 2013 12:51 PM Flag

    Going Forward... Positive Signs For Major Growth in 2014

    FVRG Folks,

    Many small companies do not experience profitability as they grow as their expenses increase at the rate of the revenue coming in, but FVRG's business model is set up to capture not only growth, but significant EPS going forward. One key going into 2014 for FVRG is the ability to accelerate profitability by keeping expenses down, as noted below, as they experience major growth. Additionally, we all know that the FDA Medical Device Listed FGXpress Powerstrips are the driver for the continued growth into 2014. The best part about that is they have very, very nice margins and now account for over half of FVRG's revenue. With this being said, the distributors for FGXpress as of Sep. 25th were approximately 15,000 and now stand above 25,000 according to the latest conference call. This happened in a 7 week period. During this time, for just the month of October, sales were approximately the same as the entire Q1 at $2.7 million. "Our sales, just for the month, were equivalent to our sales for the entire first quarter and were approximately 145% higher than October 2012. The Company is over 20% ahead of September 2013 sales."

    Q3 Report: •Sales increased to $4,793,782 from $3,060,736 for Q3 2012, a 56.6% increase

    "The Company operating expenses increased only 21.1%, showing that our business model is very scalable...We look forward to accelerated growth moving forward with all earnings, profit and cash metrics continuing to improve."

    From a Sep 12 report: "We have two major factors that are driving our growth and profitability beyond any prior historical levels. First, we have a Class I FDA listed medical device to market, and secondly we are selling in 136 countries."

    Finally, I have noticed little discussion about what R&D is currently working on, which is basically an expansion of the FGXpress line in a "catalog" type of system including one particular product Ron is "very, very excited about." Imagine the possibilities ahead.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies

      The Company's financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern. The Company has not yet established an ongoing source of revenues sufficient to cover its operating costs and to allow it to continue as a going concern. The Company has an accumulated net loss totaling $35,253,603. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations.

      • 1 Reply to lenny780
      • Lenny780,

        With all due respect, this is a small market cap growth play and nearly every public company will have similar warnings to investors in their SEC filings. This is not any different in this situation. Amazon accumulated deficit in 2005 was $2.2 billion. Twitter was $418.6 million before going public and should be going up to around $750 million soon. What is important is what is happening now. The balance sheet looks very healthy and will only get stronger in 2014. Good luck to you.

    • Spot on snap... If they can bring another FDA approved device to market....Imagine that... Not only considering that the FGXpress strips are in the virgin stages of growth.. Who really knows where this could go... I have my buy orders in, but they haven't filled yet.. I'm trying to get in at $1.62.... I'm about to bite the bullet and get in here, but I'm going to try to get them there, either way I'm not going to monkey around to long.. I am not going to miss the bus when it pulls out...

      Sentiment: Strong Buy

0.350.00(0.00%)Sep 23 3:45 PMEDT